DIRECT SODIUM REMOVAL Trademark

Trademark Overview

On Tuesday, August 18, 2020, a trademark application was filed for DIRECT SODIUM REMOVAL with the United States Patent and Trademark Office. The USPTO has given the DIRECT SODIUM REMOVAL trademark a serial number of 90122342. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, June 2, 2023. This trademark is owned by Sequana Medical NV. The DIRECT SODIUM REMOVAL trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Solutions, infusates, dialysates, compositions, all being pharmaceutical preparations used in the management of fluid overload in liver disease, malignant ascites, and heart failure

Medical devices used in the management of fluid overload in liver disease, malignant ascites, and heart failure
direct sodium removal

General Information

Serial Number90122342
Word MarkDIRECT SODIUM REMOVAL
Filing DateTuesday, August 18, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, June 2, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesSolutions, infusates, dialysates, compositions, all being pharmaceutical preparations used in the management of fluid overload in liver disease, malignant ascites, and heart failure
Goods and ServicesMedical devices used in the management of fluid overload in liver disease, malignant ascites, and heart failure

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 22, 2020
Primary Code005
First Use Anywhere DateFriday, October 4, 2019
First Use In Commerce DateFriday, October 4, 2019
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, September 22, 2020
Primary Code010
First Use Anywhere DateFriday, October 4, 2019
First Use In Commerce DateFriday, October 4, 2019

Trademark Owner History

Party NameSequana Medical NV
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSint-Denijs-Westrem 9051
BE

Trademark Events

Event DateEvent Description
Friday, June 2, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, June 2, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, June 2, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, November 18, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, November 18, 2022FINAL REFUSAL E-MAILED
Friday, November 18, 2022FINAL REFUSAL WRITTEN
Tuesday, July 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 12, 2022NON-FINAL ACTION E-MAILED
Wednesday, January 12, 2022NON-FINAL ACTION WRITTEN
Wednesday, January 12, 2022NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, January 11, 2022USE AMENDMENT ACCEPTED
Monday, July 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 12, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 12, 2021ASSIGNED TO LIE
Friday, May 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 29, 2021AMENDMENT TO USE PROCESSING COMPLETE
Saturday, May 29, 2021USE AMENDMENT FILED
Friday, May 28, 2021TEAS AMENDMENT OF USE RECEIVED
Wednesday, December 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 16, 2020NON-FINAL ACTION E-MAILED
Wednesday, December 16, 2020NON-FINAL ACTION WRITTEN
Sunday, December 13, 2020ASSIGNED TO EXAMINER
Tuesday, September 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 21, 2020NEW APPLICATION ENTERED

Related Keywords

removal sodium direct disease liver overload malignant ascites failure heart management fluid used